LifeMD (LFMDP) Competitors $23.98 +0.18 (+0.74%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock LFMDP vs. ACONW, AONC, DHACW, FMS, OTRKP, PIIIW, TALKW, TOIIW, VSEE, and NTRAShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), VSee Health (VSEE), and Natera (NTRA). These companies are all part of the "healthcare" industry. LifeMD vs. Its Competitors Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA Ontrak P3 Health Partners Talkspace Oncology Institute VSee Health Natera Aclarion (NASDAQ:ACONW) and LifeMD (NASDAQ:LFMDP) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, media sentiment, earnings and valuation. Does the media prefer ACONW or LFMDP? In the previous week, LifeMD had 1 more articles in the media than Aclarion. MarketBeat recorded 2 mentions for LifeMD and 1 mentions for Aclarion. Aclarion's average media sentiment score of 1.91 beat LifeMD's score of 0.97 indicating that Aclarion is being referred to more favorably in the media. Company Overall Sentiment Aclarion Very Positive LifeMD Positive Which has higher valuation and earnings, ACONW or LFMDP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$62.95KN/AN/AN/AN/ALifeMD$245.56MN/AN/AN/AN/A Is ACONW or LFMDP more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A LifeMD N/A N/A N/A SummaryLifeMD beats Aclarion on 2 of the 3 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMDP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFMDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMDP vs. The Competition Export to ExcelMetricLifeMDHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$343.35M$5.69B$10.27BDividend Yield11.99%5.88%5.72%4.60%P/E RatioN/A531.7475.8626.51Price / SalesN/A237.11489.92165.26Price / CashN/A47.1425.8129.89Price / BookN/A5.1112.846.32Net IncomeN/A-$15.55M$3.28B$270.51M7 Day Performance0.68%3.02%0.22%2.15%1 Month Performance0.93%2.28%4.61%6.35%1 Year Performance6.08%10.68%68.33%25.48% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDPLifeMDN/A$23.98+0.7%N/A+7.2%$0.00$245.56M0.00230Short Interest ↓ACONWAclarionN/A$0.03-0.6%N/A-12.9%$0.00$62.95K0.007Gap DownAONCAmerican Oncology NetworkN/A$11.00+2.3%N/A+201.4%$0.00$1.34B0.001,520Short Interest ↑Gap UpDHACWDigital Health AcquisitionN/A$0.03-0.7%N/AN/A$0.00N/A0.00N/AGap UpFMSFresenius Medical Care AG & Co. KGaA3.8584 of 5 stars$25.30+0.8%$27.80+9.9%+17.1%$0.00$20.63B20.741,384OTRKPOntrakN/A$0.04+75.0%N/A-86.0%$0.00$10.84M0.00250Gap DownHigh Trading VolumePIIIWP3 Health PartnersN/A$0.01+8.6%N/AN/A$0.00$1.46B0.00500TALKWTalkspaceN/A$0.08+3.1%N/A+64.4%$0.00$202.61M0.00500Gap UpTOIIWOncology InstituteN/A$0.11-10.2%N/A+455.6%$0.00$424.38M0.00660Negative NewsGap DownVSEEVSee Health2.0877 of 5 stars$0.67+0.6%$5.00+643.4%-56.6%$0.00$10.42M0.00N/ANews CoveragePositive NewsUpcoming EarningsShort Interest ↓Gap DownHigh Trading VolumeNTRANatera3.4348 of 5 stars$176.37+5.4%$194.00+10.0%+36.1%$22.97B$1.70B0.004,434Positive News Related Companies and Tools Related Companies ACONW Alternatives AONC Alternatives DHACW Alternatives FMS Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives VSEE Alternatives NTRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMDP) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
